CARDIAC SARCOIDOSIS

Clinical trials for CARDIAC SARCOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new CARDIAC SARCOIDOSIS trials appear

Sign up with your email to follow new studies for CARDIAC SARCOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Completed 1

Stanford tests arthritis drug to tame dangerous heart inflammation

Disease control Not yet recruiting

This study is testing if adding the drug baricitinib to standard therapy can better control active inflammation in the hearts of adults with cardiac sarcoidosis. Ten participants will take the drug combination for 16 weeks while doctors monitor their heart scans and symptoms. The…

Matched conditions: CARDIAC SARCOIDOSIS

Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control

Last updated Feb 20, 2026 14:36 UTC

CARDIAC SARCOIDOSIS

Get alerted when new CARDIAC SARCOIDOSIS trials appear

Stanford tests arthritis drug to tame dangerous heart inflammation